The estimated Net Worth of Donald G Payan is at least $959 millier dollars as of 30 August 2016. Donald Payan owns over 5,303 units of Rigel Pharmaceuticals stock worth over $687,812 and over the last 21 years Donald sold RIGL stock worth over $271,112.
Donald has made over 7 trades of the Rigel Pharmaceuticals stock since 2009, according to the Form 4 filled with the SEC. Most recently Donald sold 5,303 units of RIGL stock worth $21,212 on 30 August 2016.
The largest trade Donald's ever made was exercising 41,666 units of Rigel Pharmaceuticals stock on 10 June 2015 worth over $89,165. On average, Donald trades about 4,412 units every 112 days since 2003. As of 30 August 2016 Donald still owns at least 53,031 units of Rigel Pharmaceuticals stock.
You can see the complete history of Donald Payan stock trades at the bottom of the page.
Donald's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke et Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: